PBS Biotech
All resources
White Paper

Cost-Effective Scaling of Cell Therapies

Abstract

This white paper examines the cost and operational advantages of scaling cell therapy manufacturing with Vertical-Wheel® bioreactors compared with planar culture and stirred-tank systems. It evaluates expansion efficiency, labor, facility footprint, process consistency, contamination risk, and cell quality. Published studies in hiPSCs and MSCs are used to assess yield, handling requirements, reproducibility, viability, phenotype, potency, and scale-up performance. A side-by-side cost comparison, including a 3 L PBS Biotech system, illustrates how Vertical-Wheel bioreactors can support a more streamlined and scalable manufacturing approach while recognizing that actual costs depend on the specific process.

This page summarizes the document. The full white paper, including methods, figures and data, is available to view or download with a free account.
Access this documentLog in or create a free account to view the full white paper.

Looking for Data on Your Cell Type?

Browse cell-type pages for curated protocols and scaling data, or ask our scientists directly.